Nicotine promotes e-cigarette vapour-induced lung inflammation and structural alterations
Elsa T Roxlau,Oleg Pak,Stefan Hadzic,Claudia F Garcia-Castro,Marija Gredic,Cheng-Yu Wu,Julia Schäffer,Balachandar Selvakumar,Alexandra Pichl,David Spiegelberg,Janik Deutscher,Mariola Bednorz,Katharina Schäfer,Simone Kraut,Djuro Kosanovic,Esraa M Zeidan,Baktybek Kojonazarov,Susanne Herold,Ievgen Strielkov,Andreas Guenther,Jochen Wilhelm,Mohamed M A Khalifa,Ashraf Taye,Ralf P Brandes,Matthias Hecker,Friedrich Grimminger,Hossein A Ghofrani,Ralph T Schermuly,Werner Seeger,Natascha Sommer,Norbert Weissmann
DOI: https://doi.org/10.1183/13993003.00951-2022
2023-06-22
Abstract:Background: Electronic cigarette (e-cigarette) vapour is gaining popularity as an alternative to tobacco smoking and can induce acute lung injury. However, the specific role of nicotine in e-cigarette vapour and its long-term effects on the airways, lung parenchyma and vasculature remain unclear. Results: In vitro exposure to nicotine-containing e-cigarette vapour extract (ECVE) or to nicotine-free e-cigarette vapour extract (NF ECVE) induced changes in gene expression of epithelial cells and pulmonary arterial smooth muscle cells (PASMCs), but ECVE in particular caused functional alterations (e.g. a decrease in human and mouse PASMC proliferation by 29.3±5.3% and 44.3±8.4%, respectively). Additionally, acute inhalation of nicotine-containing e-cigarette vapour (ECV) but not nicotine-free e-cigarette vapour (NF ECV) increased pulmonary endothelial permeability in isolated lungs. Long-term in vivo exposure of mice to ECV for 8 months significantly increased the number of inflammatory cells, in particular lymphocytes, compared to control and NF ECV in the bronchoalveolar fluid (BALF) (ECV: 853.4±150.8 cells·mL-1; control: 37.0±21.1 cells·mL-1; NF ECV: 198.6±94.9 cells·mL-1) and in lung tissue (ECV: 25.7±3.3 cells·mm-3; control: 4.8±1.1 cells·mm-3; NF ECV: 14.1±2.2 cells·mm-3). BALF cytokines were predominantly increased by ECV. Moreover, ECV caused significant changes in lung structure and function (e.g. increase in airspace by 17.5±1.4% compared to control), similar to mild tobacco smoke-induced alterations, which also could be detected in the NF ECV group, albeit to a lesser degree. In contrast, the pulmonary vasculature was not significantly affected by ECV or NF ECV. Conclusions: NF ECV components induce cell type-specific effects and mild pulmonary alterations, while inclusion of nicotine induces significant endothelial damage, inflammation and parenchymal alterations.